ADIPOQ and coronary artery disorder: Subgroup analysis of diabetic versus non-diabetic CAD patients' serum, identified a significant difference in adiponectin levels (diabetic: 9.8 μg/mL ± 0.9 (mean ± SEM); non-diabetic: 12.7 μg/mL ± 1.0, P < 0.05).